Dan Suesskind Purchases 50,000 Shares of Nano-X Imaging (NASDAQ:NNOX) Stock

Nano-X Imaging Ltd. (NASDAQ:NNOX) Director Dan Suesskind bought 50,000 shares of the stock in a transaction that occurred on Monday, July 27th. The shares were purchased at an average price of $0.93 per share, with a total value of $46,500.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at $46,500. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Nano-X Imaging Stock Performance

Shares of NNOX opened at $0.88 on Wednesday. The stock has a market capitalization of $61.08 million, a PE ratio of -0.56 and a beta of 1.24. The company’s 50-day simple moving average is $1.47 and its 200-day simple moving average is $2.08. Nano-X Imaging Ltd. has a 1 year low of $0.73 and a 1 year high of $5.15.

Nano-X Imaging (NASDAQ:NNOX) last issued its quarterly earnings results on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The business had revenue of $4.31 million during the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. On average, sell-side analysts predict that Nano-X Imaging Ltd. will post -0.6 earnings per share for the current year.

Institutional Investors Weigh In On Nano-X Imaging

Large investors have recently modified their holdings of the company. Bank of America Corp DE increased its holdings in shares of Nano-X Imaging by 711.1% in the 1st quarter. Bank of America Corp DE now owns 484,328 shares of the company’s stock valued at $1,099,000 after acquiring an additional 424,618 shares during the period. Royal Bank of Canada boosted its stake in Nano-X Imaging by 27.8% during the 1st quarter. Royal Bank of Canada now owns 194,166 shares of the company’s stock worth $440,000 after purchasing an additional 42,273 shares during the period. Sei Investments Co. purchased a new position in Nano-X Imaging during the 1st quarter worth $98,000. Independent Financial Group LLC acquired a new position in Nano-X Imaging in the first quarter valued at $26,000. Finally, Hsbc Holdings PLC purchased a new stake in shares of Nano-X Imaging in the first quarter valued at about $35,000. 21.49% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on NNOX shares. D. Boral Capital restated a “buy” rating and issued a $5.00 price target on shares of Nano-X Imaging in a research note on Monday, April 20th. Zacks Research raised shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Wednesday, July 8th. Finally, Alliance Global Partners cut shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and lowered their target price for the company from $5.00 to $3.00 in a report on Tuesday, July 7th. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $4.00.

Trending Headlines about Nano-X Imaging

Here are the key news stories impacting Nano-X Imaging this week:

• Positive Sentiment: CEO Erez Meltzer purchased 36,000 NNOX shares at an average price of $0.93, investing approximately $33,480. The insider purchase may indicate management confidence in the company, although the relatively small transaction is unlikely to outweigh broader risks. SEC insider ownership filing
• Neutral Sentiment: Several law firms, including Rosen, Faruqi & Faruqi, Portnoy, Robbins, Pomerantz and others, are reminding investors about an August 11, 2026 deadline to seek lead-plaintiff status in a securities class action. These announcements are primarily investor solicitations, but their frequency increases attention surrounding Nano-X. Faruqi class action deadline notice
• Negative Sentiment: Pomerantz announced that a class action has been filed against Nano-X and certain officers. The lawsuit covers investors who purchased securities from March 31, 2025, through April 17, 2026, and adds potential litigation, reputational and legal-cost risks. The allegations have not been proven in court. Pomerantz class action announcement
• Negative Sentiment: The allegations focus on allegedly undisclosed cash burn and rising operating expenses preceding a $17.5 million impairment. Nano-X also continues to report losses, including quarterly revenue of $4.31 million and a loss of $0.16 per share, while analysts expect a full-year loss. SueWallSt class action notice

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.